These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23523670)

  • 1. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.
    Holczbauer Á; Factor VM; Andersen JB; Marquardt JU; Kleiner DE; Raggi C; Kitade M; Seo D; Akita H; Durkin ME; Thorgeirsson SS
    Gastroenterology; 2013 Jul; 145(1):221-231. PubMed ID: 23523670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
    Marquardt JU; Raggi C; Andersen JB; Seo D; Avital I; Geller D; Lee YH; Kitade M; Holczbauer A; Gillen MC; Conner EA; Factor VM; Thorgeirsson SS
    Hepatology; 2011 Sep; 54(3):1031-42. PubMed ID: 21618577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties.
    Pez F; Gifu P; Degli-Esposti D; Fares N; Lopez A; Lefrançois L; Michelet M; Rivoire M; Bancel B; Sylla BS; Herceg Z; Merle P; Caron de Fromentel C
    Exp Cell Res; 2019 Nov; 384(2):111643. PubMed ID: 31557464
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
    Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
    Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necroptosis microenvironment directs lineage commitment in liver cancer.
    Seehawer M; Heinzmann F; D'Artista L; Harbig J; Roux PF; Hoenicke L; Dang H; Klotz S; Robinson L; Doré G; Rozenblum N; Kang TW; Chawla R; Buch T; Vucur M; Roth M; Zuber J; Luedde T; Sipos B; Longerich T; Heikenwälder M; Wang XW; Bischof O; Zender L
    Nature; 2018 Oct; 562(7725):69-75. PubMed ID: 30209397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.
    Cerec V; Glaise D; Garnier D; Morosan S; Turlin B; Drenou B; Gripon P; Kremsdorf D; Guguen-Guillouzo C; Corlu A
    Hepatology; 2007 Apr; 45(4):957-67. PubMed ID: 17393521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
    Lahsnig C; Mikula M; Petz M; Zulehner G; Schneller D; van Zijl F; Huber H; Csiszar A; Beug H; Mikulits W
    Oncogene; 2009 Feb; 28(5):638-50. PubMed ID: 19015638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stemness in Liver Cancer.
    Thorgeirsson SS
    Dig Dis; 2017; 35(4):387-389. PubMed ID: 28467999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells.
    Zucchi I; Astigiano S; Bertalot G; Sanzone S; Cocola C; Pelucchi P; Bertoli G; Stehling M; Barbieri O; Albertini A; Schöler HR; Neel BG; Reinbold RA; Dulbecco R
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16940-5. PubMed ID: 18957543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stem cells: implications for hepatocarcinogenesis.
    Alison MR
    Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
    Ikenoue T; Terakado Y; Nakagawa H; Hikiba Y; Fujii T; Matsubara D; Noguchi R; Zhu C; Yamamoto K; Kudo Y; Asaoka Y; Yamaguchi K; Ijichi H; Tateishi K; Fukushima N; Maeda S; Koike K; Furukawa Y
    Sci Rep; 2016 Apr; 6():23899. PubMed ID: 27032374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
    Machida K
    Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.
    Akita H; Marquardt JU; Durkin ME; Kitade M; Seo D; Conner EA; Andersen JB; Factor VM; Thorgeirsson SS
    Cancer Res; 2014 Oct; 74(20):5903-13. PubMed ID: 25189530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
    Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
    BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.